Yongxiang Yan

发表

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1

Anping Li, Kongming Wu, Mengke Niu, 2021, Journal of Hematology & Oncology.

Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell

Zili Wang, Jizu Yi, P. Zhou, 2022, Frontiers in Immunology.

Subsequent malaria enhances virus-specific T cell immunity in SIV-infected Chinese rhesus macaques

Hui Zhang, M. Shugay, Xiaoping Chen, 2022, Cell communication and signaling : CCS.

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

Kongming Wu, P. Zhou, Q. Chu, 2019, Journal of Experimental & Clinical Cancer Research.

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors

Kongming Wu, D. Jiao, Mengke Niu, 2022, Journal of Hematology & Oncology.

CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers

Kongming Wu, Linping Xu, Ming Yi, 2020, Expert opinion on investigational drugs.

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer

Mengke Niu, Ming Yi, Yuze Wu, 2022, Journal for ImmunoTherapy of Cancer.

The redirected killing of PD-L1 positive tumor cells by the expanded mucosa-associated invariant T (MAIT) cells is mediated with a bispecific antibody targeting TCR Vα7.2 and PD-L1.

P. Zhou, Jiangang Shi, Rui Yang, 2023, Biochemical and biophysical research communications.

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates

Gengfu Xiao, Zili Wang, Cheng Peng, 2021, Cell discovery.

Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells

Zili Wang, Rui Yang, Jizu Yi, 2021, Frontiers in Immunology.

Bi-speci c Antibody Y111, Targeting PD-L1 and CD3 Considerably Enhances the Therapeutic E cacy of Adoptive Transferred Vγ2Vδ2 T Cells

Zili Wang, Rui Yang, Xin Wang, 2020 .

SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model

Yue Chen, Xiaoping Chen, Yongchao Yao, 2019, BMC Infectious Diseases.

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers

Kongming Wu, Mengke Niu, Ming Yi, 2021, Journal of Hematology & Oncology.

Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.

Zhihui Liang, M. Zhong, G. Shen, 2009, Human immunology.

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

Kongming Wu, P. Zhou, Q. Chu, 2019, Journal of experimental & clinical cancer research : CR.

Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus

Xingxing Liang, M. Ng, B. Zheng, 1988, Journal of clinical microbiology.